June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Can Higher Revenues Drive CME Group's (CME) Q3 Earnings?

Published 10/23/2017, 11:14 PM
Updated 07/09/2023, 06:31 AM
LNC
-
PRU
-
CME
-
AEL
-

CME Group Inc. (NASDAQ:CME) is set to report third-quarter earnings on Oct 26 before the market opens. The company delivered a positive earnings surprise in the last two quarters. Let’s see what it has in store for this yet-to-be reported quarter.

CME Group’s top line has likely improved owing to higher clearing and transaction fees. The company’s efforts to ramp up organic market data growth will add to the top line. The Zacks Consensus estimate for market data and information services are pegged at $96 million.

CME Group’s average daily volume (ADV) for the third quarter stood at 15.7 million contracts, up 10% year over year. Five of its six product lines delivered growth in ADV in the third quarter.

About 74% of CME Group’s metal options currently trade electronically. Metals’ ADV in the third quarter increased 42%, the highest across its six product lines.

However, license fees likely have increased on the back of transfer of the Russell products in July and aggregate changes in licenses.

The tax rate likely has increased in the third quarter, given an increase in the Illinois state income tax.

The Zacks Consensus Estimate for the third quarter is pegged at $1.16 per share on $889.9 million revenues. The bottom line reflects a 10.6% rise, while the top line translates to an increase of 5.7%, both on a year-over-year basis.

What our Quantitative Model Predicts

Our proven model does not conclusively show that CME Group is likely to beat estimates this quarter. This is because a stock needs to have the right combination of two main ingredients — a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) — for an earnings beat. But that is not the case here as elaborated below.

Zacks ESP: CME Group has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

CME Group Inc. Price and EPS Surprise

Zacks Rank: CME Group carries a Zacks Rank #3, which increases the predictive power of ESP. However, the company’s ESP of 0.00% makes surprise prediction difficult.

We caution against all Sell-rated stocks (#4 or 5) going into an earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks to Consider

Some stocks worth considering from the finance sector with the right combination of elements to come up with an earnings beat this quarter are as follows:

Prudential Financial (NYSE:PRU) is set to report third-quarter earnings on Nov 1 with an Earnings ESP of +0.07% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Lincoln National Corporation (NYSE:LNC) has an Earnings ESP of +0.05% and also holds a Zacks Rank of 2. The company is slated to report third-quarter earnings on Nov 1.

American Equity Investment Life Holding Company (NYSE:AEL) has an Earnings ESP of +0.40%. This #2 Ranked company is set to report third-quarter earnings on Nov 6.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>



Lincoln National Corporation (LNC): Free Stock Analysis Report

American Equity Investment Life Holding Company (AEL): Free Stock Analysis Report

Prudential Financial, Inc. (PRU): Free Stock Analysis Report

CME Group Inc. (CME): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.